Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2011
As of Jun 30, 2011
Q1 FY2011
As of Mar 31, 2011
Q4 FY2010
As of Dec 31, 2010
Q3 FY2010
As of Sep 30, 2010
Q2 FY2010
As of Jun 30, 2010
CURRENT ASSETS:
Cash and cash equivalents
Receivables, net
Inventory, net
Deferred tax assets, net
Other current assets
Total current assets
INVESTMENTS ($505,800 and $155,808 at fair value in 2011 and 2010, respectively)
PROPERTY AND EQUIPMENT, net
GOODWILL
INTANGIBLE ASSETS, net
DEBT ISSUANCE COSTS
OTHER ASSETS
TOTAL ASSETS
CURRENT LIABILITIES:
Current portion of long-term debt, net
Accounts payable
Accrued expenses
Total current liabilities
LONG-TERM DEBT
DEFERRED TAX LIABILITIES, net
OTHER LIABILITIES
Total liabilities
REDEEMABLE EQUITY
EQUITY:
Cephalon Stockholders' Equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized, 2,500,000 shares issued, and none outstanding
Common stock, $0.01 par value, 400,000,000 shares authorized, 81,290,845 and 79,091,532 shares issued, and 77,921,064 and 75,722,274 shares outstanding
Additional paid-in capital
Treasury stock, at cost, 3,369,781 and 3,369,258 shares
Accumulated earnings
Accumulated other comprehensive income
Total Cephalon stockholders' equity
Noncontrolling Interest
Total equity
TOTAL LIABILITIES AND EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support